オンコリスバイオファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2016/09/15 | 1,151 | 1,173 | 1,133 | 1,160 | -8 | -0.7% | 80,300 |
2016/09/14 | 1,194 | 1,202 | 1,163 | 1,168 | -37 | -3.1% | 100,100 |
2016/09/13 | 1,170 | 1,210 | 1,165 | 1,205 | +30 | +2.6% | 123,900 |
2016/09/12 | 1,154 | 1,230 | 1,151 | 1,175 | +5 | +0.4% | 285,000 |
2016/09/09 | 1,100 | 1,180 | 1,092 | 1,170 | +68 | +6.2% | 203,100 |
2016/09/08 | 1,120 | 1,120 | 1,093 | 1,102 | -16 | -1.4% | 96,000 |
2016/09/07 | 1,102 | 1,135 | 1,102 | 1,118 | -2 | -0.2% | 81,800 |
2016/09/06 | 1,124 | 1,138 | 1,111 | 1,120 | -12 | -1.1% | 73,800 |
2016/09/05 | 1,103 | 1,137 | 1,092 | 1,132 | +29 | +2.6% | 115,700 |
2016/09/02 | 1,100 | 1,141 | 1,098 | 1,103 | -20 | -1.8% | 90,700 |
2016/09/01 | 1,135 | 1,175 | 1,120 | 1,123 | +12 | +1.1% | 194,600 |
2016/08/31 | 1,125 | 1,127 | 1,081 | 1,111 | -34 | -3% | 230,000 |
2016/08/30 | 1,135 | 1,277 | 1,111 | 1,145 | +92 | +8.7% | 1,282,200 |
2016/08/29 | 1,059 | 1,065 | 1,046 | 1,053 | ±0 | ±0% | 40,300 |
2016/08/26 | 1,064 | 1,069 | 1,049 | 1,053 | -23 | -2.1% | 61,300 |
2016/08/25 | 1,101 | 1,116 | 1,075 | 1,076 | -40 | -3.6% | 85,200 |
2016/08/24 | 1,137 | 1,137 | 1,096 | 1,116 | +1 | +0.1% | 70,200 |
2016/08/23 | 1,095 | 1,144 | 1,093 | 1,115 | +9 | +0.8% | 107,700 |
2016/08/22 | 1,120 | 1,120 | 1,081 | 1,106 | +12 | +1.1% | 69,700 |
2016/08/19 | 1,111 | 1,136 | 1,050 | 1,094 | +22 | +2.1% | 193,100 |
2016/08/18 | 1,070 | 1,085 | 1,035 | 1,072 | +1 | +0.1% | 90,300 |
2016/08/17 | 1,101 | 1,118 | 1,070 | 1,071 | -49 | -4.4% | 90,600 |
2016/08/16 | 1,130 | 1,150 | 1,118 | 1,120 | -6 | -0.5% | 70,600 |
2016/08/15 | 1,170 | 1,214 | 1,126 | 1,126 | +13 | +1.2% | 198,700 |
2016/08/12 | 1,087 | 1,124 | 1,061 | 1,113 | +19 | +1.7% | 80,000 |
2016/08/10 | 1,040 | 1,157 | 1,040 | 1,094 | +35 | +3.3% | 258,300 |
2016/08/09 | 1,031 | 1,094 | 1,023 | 1,059 | +10 | +1% | 137,800 |
2016/08/08 | 1,100 | 1,100 | 1,047 | 1,049 | -71 | -6.3% | 214,800 |
2016/08/05 | 1,152 | 1,182 | 1,090 | 1,120 | -75 | -6.3% | 227,600 |
2016/08/04 | 1,205 | 1,234 | 1,191 | 1,195 | -25 | -2% | 161,900 |
2016/08/03 | 1,290 | 1,300 | 1,220 | 1,220 | -88 | -6.7% | 208,600 |
2016/08/02 | 1,318 | 1,339 | 1,275 | 1,308 | +18 | +1.4% | 312,600 |
2016/08/01 | 1,250 | 1,303 | 1,200 | 1,290 | +27 | +2.1% | 238,800 |
2016/07/29 | 1,262 | 1,359 | 1,190 | 1,263 | +1 | +0.1% | 656,300 |
2016/07/28 | 1,170 | 1,344 | 1,170 | 1,262 | +94 | +8% | 1,012,700 |
2016/07/27 | 1,148 | 1,168 | 1,148 | 1,168 | +23 | +2% | 80,000 |
2016/07/26 | 1,135 | 1,192 | 1,134 | 1,145 | -18 | -1.5% | 151,300 |
2016/07/25 | 1,106 | 1,212 | 1,088 | 1,163 | +27 | +2.4% | 235,600 |
2016/07/22 | 1,150 | 1,172 | 1,073 | 1,136 | +66 | +6.2% | 264,800 |
2016/07/21 | 1,100 | 1,100 | 1,052 | 1,070 | ±0 | ±0% | 106,100 |
2016/07/20 | 1,053 | 1,114 | 1,050 | 1,070 | -7 | -0.6% | 123,200 |
2016/07/19 | 1,045 | 1,098 | 1,042 | 1,077 | -23 | -2.1% | 177,600 |
2016/07/15 | 1,165 | 1,169 | 1,068 | 1,100 | -64 | -5.5% | 266,300 |
2016/07/14 | 1,162 | 1,212 | 1,160 | 1,164 | -9 | -0.8% | 146,900 |
2016/07/13 | 1,214 | 1,249 | 1,164 | 1,173 | -39 | -3.2% | 177,800 |
2016/07/12 | 1,160 | 1,220 | 1,151 | 1,212 | +60 | +5.2% | 212,300 |
2016/07/11 | 1,187 | 1,187 | 1,125 | 1,152 | +3 | +0.3% | 158,800 |
2016/07/08 | 1,189 | 1,210 | 1,120 | 1,149 | -27 | -2.3% | 240,800 |
2016/07/07 | 1,281 | 1,285 | 1,175 | 1,176 | -94 | -7.4% | 407,200 |
2016/07/06 | 1,280 | 1,342 | 1,215 | 1,270 | +18 | +1.4% | 843,500 |
2001~
2050
件表示中 / 2679件
類似銘柄と比較する
現在ご覧いただいている「オンコリス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
オンコリス | 70,300円 | +58.7% | - | 0.00% | - | 12.39倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
大幸薬品 | 36,400円 | +11.1% | - | 0.00% | 33.21倍 | 2.26倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
ヘリオス | 19,600円 | +395.9% | - | 0.00% | - | 5.45倍 |
|
iPS細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
Chordia | 24,900円 | - | - | 0.00% | - | 4.08倍 |
|
RNA制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
CANBAS | 88,700円 | - | - | 0.00% | - | 7.35倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
市場注目の銘柄
チャート関連のコラム